{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:40:23Z","timestamp":1773243623230,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s12325-008-0057-3","type":"journal-article","created":{"date-parts":[[2008,5,17]],"date-time":"2008-05-17T08:57:10Z","timestamp":1211014630000},"page":"496-501","source":"Crossref","is-referenced-by-count":21,"title":["Breast cancer low-penetrance allele 1100delC in the CHEK2 gene: Not present in the Chinese familial breast cancer population"],"prefix":"10.1007","volume":"25","author":[{"given":"Wang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Yurong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Liansheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,15]]},"reference":[{"key":"57_CR1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","volume":"2","author":"D.M. Parkin","year":"2001","unstructured":"Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533\u2013543.","journal-title":"Lancet Oncol."},{"key":"57_CR2","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1056\/NEJMra012284","volume":"348","author":"R. Wooster","year":"2003","unstructured":"Wooster R, Weber BL. Breast and ovarian cancer. N Engl J Med. 2003;348:2339\u20132347.","journal-title":"N Engl J Med."},{"key":"57_CR3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"M.C. King","year":"2003","unstructured":"King MC, Marks JR, Mandell JB. The New York Breast Cancer Study Group. Risks of breast and ovarian cancer due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302:643\u2013646.","journal-title":"Science"},{"key":"57_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrc726","volume":"2","author":"S.A. Narod","year":"2002","unstructured":"Narod SA. Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer. 2002;2:113\u2013123.","journal-title":"Nat Rev Cancer"},{"key":"57_CR5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1086\/318187","volume":"68","author":"J. Cui","year":"2001","unstructured":"Cui J, Antoniou AC, Dite GS, et al. After BRCA1 and BRCA2 \u2014 what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am J Hum Genet. 2001;68:420\u2013431.","journal-title":"Am J Hum Genet."},{"key":"57_CR6","first-page":"55","volume":"31","author":"H. Meijers-Heijboer","year":"2004","unstructured":"Meijers-Heijboer H, van den Ouweland A, Klijin J, et al. Low-penetrance susceptibility to breast cancer due to CHEK2 1100delC in non-carriers of BRCA1 or BRCA2 mutations. Nat Genet. 2004;31:55\u201359.","journal-title":"Nat Genet."},{"key":"57_CR7","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1086\/375121","volume":"72","author":"H. Meijers-Heijboer","year":"2003","unstructured":"Meijers-Heijboer H, Wijnen J, Vasen H, et al. The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genget. 2003;72:1308\u20131314.","journal-title":"Am J Hum Genget."},{"key":"57_CR8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/humu.9083","volume":"20","author":"X. Zhi","year":"2002","unstructured":"Zhi X, Csilla S, Chopin S, et al. BRCA1 and BRCA2 sequence variants in Chinese breast cancer families human mutation. Hum Mutat. 2002;20:474.","journal-title":"Hum Mutat."},{"key":"57_CR9","first-page":"12","volume":"16","author":"S.A. Miller","year":"1998","unstructured":"Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human neucleated cells. Nucleic Acids Res. 1998;16:12\u201315.","journal-title":"Nucleic Acids Res."},{"key":"57_CR10","doi-asserted-by":"crossref","first-page":"R629","DOI":"10.1186\/bcr933","volume":"6","author":"D.M. Friedrichsen","year":"2004","unstructured":"Friedrichsen DM, Malone KE, Doody DR, et al. Frequency of CHEK2 mutations in population based, case-control study of breast cancer in young women. Breast Cancer Res. 2004;6:R629\u2013R635.","journal-title":"Breast Cancer Res."},{"key":"57_CR11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/35103059","volume":"2","author":"J. Bartek","year":"2001","unstructured":"Bartek J, Falck J, Lucas J. CHK2 kinase: a busy messenger. Nat Rev. 2001;2:877\u2013886.","journal-title":"Nat Rev."},{"key":"57_CR12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","volume":"3","author":"J. Bartek","year":"2003","unstructured":"Bartek J, Lukas J. Chk1 and Chk2 kinase in checkpoint control and cancer. Cancer Cell. 2003;3:421\u2013429.","journal-title":"Cancer Cell."},{"key":"57_CR13","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1126\/science.286.5449.2528","volume":"286","author":"D.W. Bell","year":"1999","unstructured":"Bell DW, Varley JM, Szydlo TE, et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science. 1999;286:2528\u20132531.","journal-title":"Science"},{"key":"57_CR14","doi-asserted-by":"crossref","unstructured":"Chek2 Breast Cancer Case-Control Consortium. Chek2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9065 controls from 10 studies. Am J Hum Genet. 2004;74:1175\u20131182.","DOI":"10.1086\/421251"},{"key":"57_CR15","first-page":"8153","volume":"63","author":"R.A. Oldenburg","year":"2003","unstructured":"Oldenburg RA, Kroeze-Jansema K, Kraan J, et al. The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1\/BRCA2 multiple-case families. Cancer Res. 2003;63:8153\u20138157.","journal-title":"Cancer Res."},{"key":"57_CR16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/373965","volume":"72","author":"M. Schutte","year":"2003","unstructured":"Schutte M, Seal S, Barfoot R, et al. Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility. Am J Hum Genet. 2003;72:1023\u20131028.","journal-title":"Am J Hum Genet."},{"key":"57_CR17","first-page":"809","volume":"12","author":"B. Kuschel","year":"2003","unstructured":"Kuschel B, Auranen A, Gregory CS, et al. Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12:809\u2013812.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"57_CR18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ijc.20299","volume":"111","author":"O. Kilpivaara","year":"2004","unstructured":"Kilpivaara O, Vahteristo P, Falck J, et al. CHEK2 variant I157T may be associated with increased breast cancer risk. Int J Cancer. 2004;111:543\u2013547.","journal-title":"Int J Cancer."},{"key":"57_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10549-005-1409-1","volume":"92","author":"B. G\u00f3rski","year":"2005","unstructured":"G\u00f3rski B, Cybulski C, Huzarski T, et al. Breast cancer predisposing alleles in poland. Breast Cancer Res Treat. 2005;92:19\u201324.","journal-title":"Breast Cancer Res Treat."},{"key":"57_CR20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/341943","volume":"71","author":"P. Vahteristo","year":"2002","unstructured":"Vahteristo P, Bartkova J, Eerola H, et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet. 2002;71:432\u2013438.","journal-title":"Am J Hum Genet."},{"key":"57_CR21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ijc.11414","volume":"108","author":"A. Osorio","year":"2004","unstructured":"Osorio A, Rodr\u00edguez-L\u00f3pez R, D\u00edez O, et al. The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Int J Cancer. 2004;108:54\u201356.","journal-title":"Int J Cancer."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0057-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-008-0057-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0057-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:55:51Z","timestamp":1559447751000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-008-0057-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1007\/s12325-008-0057-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}